beta-glucan — Drug Target
All drugs that target beta-glucan — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (1)
- CD101 · Cidara Therapeutics Inc. · Antifungal · Infectious Disease
CD101 is a recombinant human monoclonal antibody targeting beta-glucan.